Molecular Diagnostic System Using Engineered Fusion Protein-Conjugated Magnetic Nanoparticles
journal contributionposted on 10.12.2021, 07:13 by Juyoung Kang, Donguk Kang, Gyuho Yeom, Chin-Ju Park
To effectively control the spread of new infectious diseases, there is a need for highly sensitive diagnostic methods to detect viral nucleic acids rapidly. This study outlines a universal and simple detection strategy that uses magnetic nanoparticles (MNPs) and a novel MagR-MazE fusion protein for molecular diagnostics to facilitate sensitive detection. This study has engineered a novel MNP conjugate that can be generated easily, without using many chemical reagents. The technique is a nucleic acid detection method, using MagR-MazE fusion protein-conjugated MNPs, where the results can be visualized with the naked eye, regardless of the oligonucleotide sequences of the target in the lateral flow assay. This method could sensitively detect polymerase chain reaction (PCR) products of 16S ribosomal RNA (rRNA) and the 2019-nCoV-N-positive control gene in 5 min. It shows a low limit of detection (LoD) of 0.013 ng/μL for dsDNA. It is simpler and more rapid, sensitive, and versatile than other techniques, making it suitable for point-of-care testing. The proposed detection system and MNP conjugation strategy using a fusion protein can be widely applied to various fields requiring rapid on-site diagnosis.
Read the peer-reviewed publication
uses magnetic nanoparticlesnew infectious diseaseslateral flow assay16s ribosomal rnasimple detection strategyproposed detection systempositive control genenovel mnp conjugateconjugated magnetic nanoparticlesmaze fusion proteinfacilitate sensitive detectionfusion proteinnovel magreffectively controlwidely appliedusing magrsite diagnosisoligonucleotide sequencesnaked eyemolecular diagnosticslow limitgenerated easilyconjugated mnpscare testing5 min013 ng